Loomis, Sayles & Company
NVS icon

Loomis, Sayles & Company’s Novartis NVS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$675M Buy
5,581,576
+78,483
+1% +$9.5M 0.85% 24
2025
Q1
$613M Sell
5,503,093
-73,868
-1% -$8.23M 0.89% 26
2024
Q4
$543M Sell
5,576,961
-192,677
-3% -$18.7M 0.69% 31
2024
Q3
$664M Sell
5,769,638
-175,745
-3% -$20.2M 0.87% 26
2024
Q2
$633M Buy
5,945,383
+27,411
+0.5% +$2.92M 0.87% 26
2024
Q1
$572M Sell
5,917,972
-91,928
-2% -$8.89M 0.81% 30
2023
Q4
$607M Sell
6,009,900
-56,717
-0.9% -$5.73M 0.93% 29
2023
Q3
$618M Sell
6,066,617
-248,393
-4% -$25.3M 1.06% 24
2023
Q2
$637M Sell
6,315,010
-292,139
-4% -$29.5M 1.03% 26
2023
Q1
$608M Sell
6,607,149
-4,338,849
-40% -$399M 1.05% 25
2022
Q4
$993M Sell
10,945,998
-3,983,754
-27% -$361M 1.99% 15
2022
Q3
$1.13B Sell
14,929,752
-555,468
-4% -$42.2M 2.3% 16
2022
Q2
$1.31B Sell
15,485,220
-1,821,967
-11% -$154M 2.43% 11
2022
Q1
$1.52B Sell
17,307,187
-586,379
-3% -$51.5M 2.03% 17
2021
Q4
$1.57B Sell
17,893,566
-1,045,879
-6% -$91.5M 1.89% 16
2021
Q3
$1.55B Sell
18,939,445
-80,144
-0.4% -$6.55M 1.9% 17
2021
Q2
$1.74B Sell
19,019,589
-749,188
-4% -$68.4M 2.1% 16
2021
Q1
$1.69B Sell
19,768,777
-348,952
-2% -$29.8M 2.19% 16
2020
Q4
$1.9B Buy
20,117,729
+9,611,979
+91% +$908M 2.51% 14
2020
Q3
$914M Sell
10,505,750
-38,369
-0.4% -$3.34M 1.33% 22
2020
Q2
$921M Buy
10,544,119
+136,363
+1% +$11.9M 1.48% 19
2020
Q1
$858M Buy
10,407,756
+142,624
+1% +$11.8M 1.77% 18
2019
Q4
$972M Buy
10,265,132
+3,162,317
+45% +$299M 1.65% 23
2019
Q3
$617M Buy
7,102,815
+74,679
+1% +$6.49M 1.19% 30
2019
Q2
$642M Buy
7,028,136
+16,801
+0.2% +$1.53M 1.2% 30
2019
Q1
$674M Buy
7,011,335
+47,186
+0.7% +$4.54M 1.32% 29
2018
Q4
$598M Sell
6,964,149
-381,770
-5% -$32.8M 1.41% 27
2018
Q3
$633M Buy
7,345,919
+136,220
+2% +$11.7M 1.24% 27
2018
Q2
$545M Sell
7,209,699
-592,387
-8% -$44.7M 1.1% 30
2018
Q1
$631M Buy
7,802,086
+887,198
+13% +$71.7M 1.34% 24
2017
Q4
$581M Buy
6,914,888
+114,781
+2% +$9.64M 1.21% 26
2017
Q3
$584M Buy
6,800,107
+168,494
+3% +$14.5M 1.27% 26
2017
Q2
$554M Buy
6,631,613
+390,374
+6% +$32.6M 1.3% 24
2017
Q1
$464M Buy
6,241,239
+41,762
+0.7% +$3.1M 1.16% 28
2016
Q4
$452M Buy
6,199,477
+349,039
+6% +$25.4M 1.11% 28
2016
Q3
$462M Buy
5,850,438
+249,227
+4% +$19.7M 1.17% 28
2016
Q2
$462M Buy
5,601,211
+358,263
+7% +$29.6M 1.26% 27
2016
Q1
$380M Buy
5,242,948
+408,972
+8% +$29.6M 1.08% 28
2015
Q4
$416M Buy
4,833,976
+233,886
+5% +$20.1M 1.17% 27
2015
Q3
$423M Buy
4,600,090
+322,926
+8% +$29.7M 1.25% 21
2015
Q2
$421M Buy
4,277,164
+663,561
+18% +$65.3M 1.15% 20
2015
Q1
$356M Buy
3,613,603
+115,175
+3% +$11.4M 0.99% 23
2014
Q4
$324M Buy
3,498,428
+68,520
+2% +$6.35M 0.9% 28
2014
Q3
$323M Buy
3,429,908
+367,277
+12% +$34.6M 0.95% 22
2014
Q2
$277M Buy
3,062,631
+186,335
+6% +$16.9M 0.79% 25
2014
Q1
$245M Buy
2,876,296
+842,551
+41% +$71.6M 0.69% 29
2013
Q4
$163M Buy
2,033,745
+20,646
+1% +$1.66M 0.49% 37
2013
Q3
$154M Buy
2,013,099
+1,148,557
+133% +$88.1M 0.5% 38
2013
Q2
$61.1K Buy
+864,542
New +$61.1K 0.22% 107